Estimating the number of relapsed and refractory indolent lymphoma patients across Europe, who are expected to initiate a new line of therapy (LOT)
Authors:
Ellis H, Neves C, Chapman A and Jeyakumaran D.
Publication type:
Poster PCN41
Conference name:
20th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress
Citation:
Ellis H, Neves C, Chapman A and Jeyakumaran D. Estimating the number of relapsed and refractory indolent lymphoma patients across Europe, who are expected to initiate a new line of therapy (LOT). 20th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Glasgow, Scotland. 4-8 November. Poster PCN41.
